Featured Research

from universities, journals, and other organizations

Link Between Alzheimer's Disease And Traumatic Brain Damage Clarified

Date:
August 16, 2005
Source:
VIB, Flanders Interuniversity Institute of Biotechnology
Summary:
This week scientists of the Flanders Interuniversity Institute for Biotechnology (VIB) will once again publish a breakthrough in their research regarding Alzheimer's disease. The researchers discovered the function of one of the most important proteins related to Alzheimer's disease. They have indicated that the protein stimulates the growth of nerve paths in the brain, which is essential for recovery after brain damage.

Leuven, Belgium – This week scientists of the FlandersInteruniversity Institute for Biotechnology (VIB) will once againpublish a breakthrough in their research regarding Alzheimer's disease.The researchers, this time connected to the Catholic University ofLeuven, discovered the function of one of the most important proteinsrelated to Alzheimer's disease. They have indicated that the proteinstimulates the growth of nerve paths in the brain, which is essentialfor recovery after brain damage. The results are published in theauthoritative journal EMBO Journal.

The normal function of theamyloidal precursor protein or APP clarified It has been known forseveral years that APP is relevant in Alzheimer's disease. APP is theprecursor of the amyloidal- protein that causes the typical 'plaques'in the brains of patients. The normal function of APP was, however, notknown. Maarten Leyssen and his colleagues have indicated that APPstimulates the development of nerve paths. Intact nerve paths areessential for the proper functioning of the brain. These connectionscan be damaged after traumatic brain damage resulting in the improperfunctioning of the brain. APP is responsible for stimulating thedevelopment of new nerve paths.

APP and Alzheimer's disease

Theseresults also aid better understanding of certain aspects of Alzheimer'sdisease, where APP plays a major role. The fruit fly – an ideal modelto study the brain's action – indicates that APP increases considerablyafter brain damage, namely in areas where new nerve paths need to beformed. Because more APP is made, more plaques can develop in thebrain, a typical symptom of Alzheimer's disease. For the first time theresults of VIB researchers explain the strong link between brain damageand Alzheimer's disease: not only do patients with major brain damagehave more chance of developing Alzheimer's disease later on in life,their brains also often show plaques that strongly resemble those ofAlzheimer patients.


Story Source:

The above story is based on materials provided by VIB, Flanders Interuniversity Institute of Biotechnology. Note: Materials may be edited for content and length.


Cite This Page:

VIB, Flanders Interuniversity Institute of Biotechnology. "Link Between Alzheimer's Disease And Traumatic Brain Damage Clarified." ScienceDaily. ScienceDaily, 16 August 2005. <www.sciencedaily.com/releases/2005/08/050814164946.htm>.
VIB, Flanders Interuniversity Institute of Biotechnology. (2005, August 16). Link Between Alzheimer's Disease And Traumatic Brain Damage Clarified. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/08/050814164946.htm
VIB, Flanders Interuniversity Institute of Biotechnology. "Link Between Alzheimer's Disease And Traumatic Brain Damage Clarified." ScienceDaily. www.sciencedaily.com/releases/2005/08/050814164946.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins